|Last Price$32.61||Day Change (%)-2.80%|
|Open Price$33.33||Day Change ($)-0.94|
|Day Range32.48–33.50||52-Week Range32.17–56.70|
As of Thu 5/27/2015 8:44:00 PM | USD
Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx
Here's your only safe bet in this sickly stock market
Canadian Journal of Urology Study Highlights the Benefits of Heparin and Alkalinized Lidocaine Combination Formulation for the Relief of Interstitial Cystitis Symptoms
Investors weigh in on the merits of switching to all-index portfolios and dividend-paying stocks, and backing up the truck in tough markets.
We don't advocate shorting, but if you're going to do it, here's how.